Publications by authors named "Guenter Fingerle-Rowson"

Claim this Profile
M
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial.
Christiane Pott, Laurie H Sehn, David Belada, John Gribben, Eva Hoster, Guenter Fingerle-Rowson

Leukemia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.
Billy Michael Chelliah Jebaraj, Eugen Tausch, Dan A Landau, Jasmin Bahlo, Sandra Robrecht, Guenter Fingerle-Rowson

Leukemia· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Magdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, Federica Cavallo, Jie Jin, Guenter R Fingerle-Rowson

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
Lale Kostakoglu, Andre Goy, Giovanni Martinelli, Dolores Caballero, Michael Crump, Guenter Fingerle-Rowson

Leuk Lymphoma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.
Tania Brocks, Oleg Fedorchenko, Nicola Schliermann, Astrid Stein, Ute M Moll, Guenter Fingerle-Rowson

FASEB J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia.
John C Byrd, Joseph M Flynn, Thomas J Kipps, Michael Boxer, Kathryn S Kolibaba, Guenter Fingerle-Rowson

Blood· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009.
Christian Schmidt, Guenter Fingerle-Rowson, Angelika Boehme, Kurt Brendel, Richard Fischer

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of indolent lymphoma in Germany - results of a representative population-based survey.
Christian Schmidt, Sebastian Fetscher, Christian Görg, Peter Kornek, Arnd Nusch, Guenter Fingerle-Rowson

Clin Lymphoma Myeloma Leuk· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis